FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034457907> ?p ?o ?g. }

• W2034457907 endingPage "137" @default.
• W2034457907 startingPage "137" @default.
• W2034457907 abstract "Zoledronic acid, an inhibitor of osteoclast-mediated bone resorption, has been shown to have both direct and indirect antitumor activity. However, its use in extraskeletal malignancy is limited due to rapid uptake and accumulation within bone. Polyinosinic acid-polycytidylic acid [poly (I:C)] is a synthetic double-stranded RNA with direct antitumor cytotoxicity if it can be delivered to tumor cells intracellularly.Cationic lipid-coated calcium phosphate nanoparticles (LCP) were developed to enable intracellular codelivery of zoledronic acid and poly (I:C). LCP codelivering zoledronic acid and poly (I:C) were prepared using an ethanol injection method. Briefly, the ethanol solution of lipids was rapidly injected into newly formed calcium phosphate crystals containing poly (I:C) and zoledronic acid, and the mixture was then sonicated briefly to form LCP. The LCP were fully characterized for mean diameter size and zeta potential, efficiency in loading zoledronic acid, cytotoxic effect in a B16BL6 melanoma cell line in vitro, and antitumor effect in B16BL6 melanoma-bearing mice.LCP with a mean diameter around 200 nm and a narrow size distribution (polydispersity index 0.17) and high zoledronic acid encapsulation efficiency (94%) were achieved. LCP loaded with zoledronic acid and poly (I:C) had significantly greater antitumor activity than the free drugs in the B16BL6 melanoma cell line (P < 0.05). Furthermore, codelivery of zoledronic acid and poly (I:C) by LCP had higher cytotoxicity than delivering poly (I:C) alone by LCP (P < 0.05), indicating a synergism between zoledronic acid and poly (I:C). Finally, the antitumor study in melanoma-bearing mice also demonstrated synergism between zoledronic acid and poly (I:C) codelivered by LCP.Cationic lipid-coated calcium phosphate nanoparticles constructed for codelivery of zoledronic acid and double-stranded RNA poly (I:C) had better antitumor activity both in vitro and in vivo. Future preclinical development of LCP encapsulating zoledronic acid and poly (I:C) for the treatment of human cancer is under way." @default.
• W2034457907 created "2016-06-24" @default.
• W2034457907 creator A5004172120 @default.
• W2034457907 creator A5037989560 @default.
• W2034457907 creator A5043398671 @default.
• W2034457907 creator A5051111034 @default.
• W2034457907 creator A5060913594 @default.
• W2034457907 creator A5076181858 @default.
• W2034457907 creator A5081050254 @default.
• W2034457907 date "2013-01-01" @default.
• W2034457907 modified "2023-10-17" @default.
• W2034457907 title "Codelivery of zoledronic acid and double-stranded RNA from core-shell nanoparticles" @default.
• W2034457907 cites W1521095066 @default.
• W2034457907 cites W1774934085 @default.
• W2034457907 cites W1794516118 @default.
• W2034457907 cites W1963541252 @default.
• W2034457907 cites W1963996829 @default.
• W2034457907 cites W1965372133 @default.
• W2034457907 cites W1965850655 @default.
• W2034457907 cites W1966652951 @default.
• W2034457907 cites W1969722896 @default.
• W2034457907 cites W1981964535 @default.
• W2034457907 cites W1982855449 @default.
• W2034457907 cites W1996523699 @default.
• W2034457907 cites W2003081275 @default.
• W2034457907 cites W2003177403 @default.
• W2034457907 cites W2007962626 @default.
• W2034457907 cites W2009603559 @default.
• W2034457907 cites W2011863989 @default.
• W2034457907 cites W2012867962 @default.
• W2034457907 cites W2020808186 @default.
• W2034457907 cites W2021140221 @default.
• W2034457907 cites W2031833830 @default.
• W2034457907 cites W2032288259 @default.
• W2034457907 cites W2035311100 @default.
• W2034457907 cites W2039483927 @default.
• W2034457907 cites W2039701074 @default.
• W2034457907 cites W2040775211 @default.
• W2034457907 cites W2041868422 @default.
• W2034457907 cites W2045031638 @default.
• W2034457907 cites W2053557358 @default.
• W2034457907 cites W2054265941 @default.
• W2034457907 cites W2059953186 @default.
• W2034457907 cites W2068106967 @default.
• W2034457907 cites W2068991926 @default.
• W2034457907 cites W2073822329 @default.
• W2034457907 cites W2083221435 @default.
• W2034457907 cites W2087882436 @default.
• W2034457907 cites W2089079020 @default.
• W2034457907 cites W2089782338 @default.
• W2034457907 cites W2104300955 @default.
• W2034457907 cites W2107370389 @default.
• W2034457907 cites W2110050889 @default.
• W2034457907 cites W2112680798 @default.
• W2034457907 cites W2117563003 @default.
• W2034457907 cites W2123047924 @default.
• W2034457907 cites W2123608544 @default.
• W2034457907 cites W2126520912 @default.
• W2034457907 cites W2130115096 @default.
• W2034457907 cites W2134507592 @default.
• W2034457907 cites W2135759608 @default.
• W2034457907 cites W2137660094 @default.
• W2034457907 cites W2146990673 @default.
• W2034457907 cites W2148334408 @default.
• W2034457907 cites W2152281757 @default.
• W2034457907 cites W2154720522 @default.
• W2034457907 cites W2169904202 @default.
• W2034457907 cites W2610711589 @default.
• W2034457907 cites W2162865536 @default.
• W2034457907 doi "https://doi.org/10.2147/ijn.s38928" @default.
• W2034457907 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3540971" @default.
• W2034457907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23319865" @default.
• W2034457907 hasPublicationYear "2013" @default.
• W2034457907 type Work @default.
• W2034457907 sameAs 2034457907 @default.
• W2034457907 citedByCount "8" @default.
• W2034457907 countsByYear W20344579072014 @default.
• W2034457907 countsByYear W20344579072016 @default.
• W2034457907 countsByYear W20344579072017 @default.
• W2034457907 countsByYear W20344579072019 @default.
• W2034457907 countsByYear W20344579072021 @default.
• W2034457907 crossrefType "journal-article" @default.
• W2034457907 hasAuthorship W2034457907A5004172120 @default.
• W2034457907 hasAuthorship W2034457907A5037989560 @default.
• W2034457907 hasAuthorship W2034457907A5043398671 @default.
• W2034457907 hasAuthorship W2034457907A5051111034 @default.
• W2034457907 hasAuthorship W2034457907A5060913594 @default.
• W2034457907 hasAuthorship W2034457907A5076181858 @default.
• W2034457907 hasAuthorship W2034457907A5081050254 @default.
• W2034457907 hasBestOaLocation W20344579071 @default.
• W2034457907 hasConcept C109316439 @default.
• W2034457907 hasConcept C13965031 @default.
• W2034457907 hasConcept C141071460 @default.
• W2034457907 hasConcept C185592680 @default.
• W2034457907 hasConcept C192562407 @default.
• W2034457907 hasConcept C202751555 @default.
• W2034457907 hasConcept C2776326535 @default.
• W2034457907 hasConcept C55493867 @default.

• next